Factors Influencing Hereditary Genetic Testing in Women with a Family and Personal History of Breast Cancer

Journal of Oncology Practice reported a study in which Scott and colleagues identified factors motivating patients at high risk of hereditary breast cancer to undergo genetic testing, and found that doctors did not recommend these tests sufficiently.
Details of the Study
The study includes data from an online survey of 1322 participants. Surveys were conducted between October 2017 - March 2018.
• Of all participants, 46% had been diagnosed with breast cancer at age <45
• 61% had a first-degree relative with cancer
• 84% had undergone genetic testing; a high-risk pathogenic variant (genetic alteration) was found in 56% of these patients
• Overall, 86% of tested patients were very satisfied with their testing decision, compared with 34% of untested patients satisfied with their decision
• Overall, 55% of those not tested said they were considering testing in the future. The most frequently cited factor that might influence discussing testing with a doctor was learning that it was often covered by health insurance (55%)
Among all participants, the most common factors encouraging genetic testing were:
• Cancer risk in relatives (75%),
• Physician recommendations (68%) and
• Potential treatment implications (67%).
Testingnotbeing pursued was most commonly influenced by:
• Lack of insurance coverage for the test (14%),
• Test cost (14%) and
• Concerns about employment or insurance discrimination (9%).
Most participants reported that doctors provided information about inheritance patterns (65%), surgical practices (65%) and other cancer risks (66%), but few doctors provided information on clinical trial eligibility implications of genetic test results (38%) or availability of targeted treatments (14%).
Patients who had received genetic counseling were twice as likely to report that doctors informed them about all topics asked about.
Survey results did not vary according to year of breast cancer diagnosis.
In conclusion, among patients at high genetic risk, physician recommendations, potential treatment applications and protections against discrimination motivated genetic testing, but fewer than half recalled receiving this information from doctors. Physicians influence decisions about hereditary cancer testing and should inform patients about legal protections and treatment applications.
Sources
Was this article helpful?
Your feedback helps us improve our content.





Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.